PHOTO
Dubai, United Arab Emirates: DP World, UAE Region’s Jebel Ali Free Zone (Jafza) witnessed a 12 per cent growth in its healthcare and pharmaceuticals customer base between 2019-2020. To showcase their commitment to promote the growth of healthcare and pharmaceutical companies, DP World, UAE Region and Jafza will participate in Arab Health 2021, one of the leading medical equipment exhibitions in the Middle East.
As one of the most important contributing sectors in the Free Zone, the healthcare and pharmaceuticals segment is one of the key economic pillars in Jafza. Spanning an area of around 170,000 sqm, and currently housing 174 companies from 41 countries, the segment provides jobs to 1,100 employees. In 2019, the volume of trade in the segment stood at 25,000 metric tonnes, valued at AED900 million.
Unlocking growth
The healthcare sector in the UAE has rapidly expanded to meet the evolving needs of the population, helping the nation in its endeavour to become a regional medical tourism hub. Partnerships and initiatives by the government and private and public sector companies are helping to achieve these goals. DP World, UAE Region and Jafza have been at the forefront, ensuring sustainable growth of this sector.
Abdulla Bin Damithan, CEO & Managing Director, DP World - UAE Region and Jafza said: “The boom in the healthcare and pharmaceuticals segment in Jafza has highlighted the core competencies of the sector in the Middle East and the seamless connectivity DP World, UAE Region offers to over 3.5 billion consumers through the highly efficient trade and logistics hub in Jebel Ali, which includes Jafza and the Jebel Ali Port. Our trade and logistics hub has expedited global distribution of COVID-19 equipment and played a key role in the Dubai Vaccine Logistics Alliance, an initiative launched in January 2021. As a smart trade enabler, we have ensured a flawless supply chain throughout 2020, irrespective of the dynamic market conditions.”
As the only free zone with the ability to support indigenous manufacturing for the healthcare and pharmaceutical sector, Jafza has facilities dedicated to the storage of ancillary vaccine preparation and administration items. Additionally, Jebel Ali Port has temperature-controlled warehouses and also consists of nearly 10,000 reefer points spread across the terminals to power refrigerated containers and support pharmaceutical trade.
Several incentives like on-demand warehouses on short term lease with multi-functional storage options, no VAT or customs duties and cost-effective transport services enhance ease of accessibility and enable speedier deliveries to benefit companies that operate in Jebel Ali. DP World, UAE Region’s and Jafza’s participation at Arab Health 2021 will open new avenues of growth for companies, further adding value to the economy of the country.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
